WORCESTER, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”) (OTC: ACTC), announced today that their study investigating the feasibility of producing functional, oxygen-carrying red blood cells (RBCs) from mature human embryonic stem cells (hESCs) has been formally published in the print version of the prestigious medical journal Blood – the leading publication in the field of hematology. The study,which was previously only available in the online edition of the Journal, includes commentary from Dr. Eric Bouhassira of the Albert Einstein College of Medicine, a leading researcher in the field of hematology.
